The pharmaceutical industry abandoned GH secretagogue development in the early 2010s not because the compounds don't workPhase 3 trials consistently demonstrated GH and IGF-1 elevationbut because the therapeutic window for meaningful clinical outcomes (muscle preservation in cachexia, bone density improvement in osteoporosis) was too narrow relative to metabolic side effects like glucose intolerance
Exploring the multifaceted Nexus of uric acid and health: a review of recent studies on Diverse diseases
Found naturally in your cells, it plays a critical role in detoxifying harmful substances, neutralizing oxidative stress, and supporting overall cellular health
Efficacy and safety of oral small molecule glucagon-like peptide 1 receptor agonist danuglipron for glycemic control among patients with type 2 diabetes: a randomized clinical trial
$175.00 A once-weekly, provider-prescribed GLP-1 injection to support for weight loss
Genes Dev 20:12831293 Elborough KM, West SC (1990) Resolution of synthetic Holliday junctions in DNA by an endonuclease activity from calf thymus